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Abstract
There are unexplained geographical variations in the incidence of kidney cancer with the high rates reported in Baltic countries,
as well as eastern and central Europe. Having access to a large and well-annotated collection of “tumor/non-tumor” pairs of
kidney cancer patients from the Czech Republic, Romania, Serbia, UK, and Russia, we aimed to analyze the morphology of non-
neoplastic renal tissue in nephrectomy specimens. By applying digital pathology, we performed a microscopic examination of
1012 frozen non-neoplastic kidney tissues from patients with renal cell carcinoma. Four components of renal parenchyma were
evaluated and scored for the intensity of interstitial inflammation and fibrosis, tubular atrophy, glomerulosclerosis, and arterial
wall thickening, globally called chronic renal parenchymal changes. Moderate or severe changes were observed in 54 (5.3%) of
patients with predominance of occurrence in Romania (OR = 2.67, CI 1.07–6.67) and Serbia (OR = 4.37, CI 1.20–15.96) in
reference to those from Russia. Further adjustment for comorbidities, tumor characteristics, and stage did not change risk
estimates. In multinomial regression model, relative probability of non-glomerular changes was 5.22 times higher for
Romania and Serbia compared to Russia. Our findings show that the frequency of chronic renal parenchymal changes, with
the predominance of chronic interstitial nephritis pattern, in kidney cancer patients varies by country, significantly more frequent
in countries located in central and southeastern Europe where the incidence of kidney cancer has been reported to be moderate to
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high. The observed association between these pathological features and living in certain geographic areas requires a larger
population-based study to confirm this association on a large scale.
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Introduction
Worldwide, kidney cancer was reported as the 9th most com-
mon malignancy in men and 14th in women in 2018, with an
estimated 136,515 and 67,424 new cases in Europe and North
America respectively. There is considerable geographic vari-
ation in the incidence of kidney cancer; the reason for that is
unknown. The highest incidence rates are reported in Baltic
countries, as well as Central and Southern Europe, with age-
standardized incidence rates of 16.8 in Belarus, followed by
Latvia (15.2), Lithuania (14.8), Czech Republic (14.7), and
Estonia (14.6) [1]. Renal cell carcinoma (RCC), the most
common malignant neoplasm in the kidney, is composed of
a heterogeneous group of carcinomas derived from the renal
tubular epithelium. The most common carcinomas in this cat-
egory are clear cell RCC, papillary RCC, and chromophobe
RCC, which globally comprise 85–90% of RCC cases.
Previous data indicate that non-neoplastic kidney tissues in
nephrectomy specimens, removed for renal neoplasms or ad-
vanced renal diseases, are rarely normal and often show var-
iable levels of pathological changes such as glomerular abnor-
malities, diabetic or hypertensive nephropathies, and chronic
pyelonephritis. It is shown that 5 to 25% of RCC patients have
varying pathologies of chronic kidney disease and those with
normal renal function are more likely to develop chronic kid-
ney disease after nephrectomy. Such changes may cause im-
pairment of renal function and reduce the patient’s quality of
life [2–5]. Through examination of non-neoplastic renal pa-
renchymal changes in 110 cancer-related nephrectomy speci-
mens, Bijol et al. showed that only 10% of the cases have
unremarkable parenchyma and those with considerable path-
ological changes such as severe parenchymal scarring and
more than 20% glomerulosclerosis had progressive worsening
of renal function in 6-month follow-up after radical nephrec-
tomy [6]. Chronic kidney disease and kidney cancer are con-
nected in both directions: the carcinogenic role of chronic
kidney diseases has been reported, and conversely, nephrec-
tomy, as the standard therapeutic approach to renal cancer, can
lead to chronic kidney disease [7, 8]. Globally, all reports
support that while non-neoplastic changes are frequent in ne-
phrectomy specimens, they are often unrecognized, so routine
pathological evaluation of non-neoplastic kidney provides
valuable diagnostic and prognostic information. On the other
hand, understanding molecular events such as somatic muta-
tions in non-neoplastic cells is central to understand cancer
development and is taking a considerable place in research
on cancer [9, 10].
During 2007 to 2016, the International Agency for
Research on Cancer (IARC)/WHO conducted hospital- and
population-based, multicentric case-control studies in the
Czech Republic, Romania, Serbia, and Russia (K2 study) to
recruit incident cases with a kidney cancer diagnosis for the
purpose of a better understanding of the epidemiology, etiol-
ogy, and genomics of renal cancer. In parallel, incident kidney
cancer cases were recruited in the United Kingdom (UK) by
the Leeds Multidisciplinary Research Tissue Bank. Both col-
lections were used in the Cancer Genomic of Kidney
(CAGEKID) project (http://www.cng.fr/cagekid/). This
collection comprises more than 2000 frozen “tumor/non-
tumor” pairs with annotated clinico-epidemiological data of
kidney cancer patients.
Having access to this multicentric and international collec-
tion, we designed this study to evaluate the morphology of
post-nephrectomy non-neoplastic kidney tissues in a subset of
the patients with RCC from our collection.
Material and methods
Study design
Collection of renal tissue pairs in both K2 and CAGEKID
studies was performed by applying harmonized standard op-
erative procedures (SOPs) throughout the participating coun-
tries. Immediately after partial or radical nephrectomy, in ad-
dition to tumor tissue, one piece of non-neoplastic tissue was
collected with the following specifications: from the renal
cortex, distant from tumor, and at least 5 mm in the largest
diameter. However, the exact distance of the collected non-
tumor tissue from tumor was not recorded. All of the collected
tissues were snap-frozen and stored in liquid nitrogen or di-
rectly immersed in RNAlater followed by freezing in − 80 °C
freezers and were then shipped to IARC for storage and pro-
cessing. Patients were interviewed and detailed information
including tobacco use, alcohol consumption, bodymass, med-
ical history, and family history of cancer, as well as clinical
data from medical records, were collected. Digital pathology
was applied for microscopic examination of frozen tissues by
a panel of expert pathologists. Non-tumor tissues were exam-
ined by a single pathologist, mainly to confirm the absence of
tumor contamination, to be used in gene expression analyses.
The current study took shape accidentally and following
some specific observations. We at IARC, responsible for
DNA/RNA extraction for the CAGEKID study, noticed lower
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RNA quality in non-tumor tissues compared to tumors. While
looking for the reason behind this observation and finding
none, we decided to have a second look at the microscopy
of non-tumor tissues to understand if there could be any mor-
phological finding relevant to this observation. BAA, pathol-
ogist at IARC, performed this examination and evaluated and
recorded the observed features, as detailed as possible. The
pathologist was blinded to tumor type, epidemiological data,
country of residence, and results of RNA quality. This first
essay on 626 tissues ended to find nothing that could explain
the quality of RNA. Instead, we found some pathologies that
our preliminary statistical analyses showed them occurring
significantly limited to specific countries. These unexpected
but interesting results led us to expand our work to a larger
number of available tissues in our biorepository and to re-
evaluate them altogether under one project and by applying
more rigorous statistical analyses. Below, we report the design
and the results of this work.
We selected 1045 non-neoplastic kidney tissues based
on the availability of at least one hematoxylin and eosin
(H&E) stained slide, irrespective of the tumor type or
the country of recruitment. High-resolution whole slide
images were used for digital microscopy by one pathol-
ogist (BAA), blind to the type and status of tumor,
demographic and clinical data, country of recruitment,
or laboratory results. We first evaluated the composition
of renal parenchyma, and if purely from cortex or con-
taining medulla as well. Four components of renal cor-
tex and their pathological changes were examined: renal
glomeruli and the presence of various degrees of glo-
merular sclerosis (GS); renal tubules and the presence
and severity of atrophy; presence and severity of inter-
stitial fibrosis (the latter two together called IFTA);
presence, severity, and type of inflammation; and also
blood vessels’ structure. All the observed changes were
recorded. We then qualitatively scored the intensity of
these changes, which were collectively called chronic
renal parenchymal changes (CRPC), from none to se-
vere as follows: none, if no significant pathological
changes were observed, and mild, moderate, and severe
if any or a complex of parenchymal changes were seen
with +, ++, or +++ intensity, respectively. We then used
the proposed scoring method by the International
Society of Nephrology (ISN) to report the microscopic
findings of the non-neoplastic renal tissues in native
kidney biopsies. In ISN scoring, the severity of changes
in each renal parenchymal component is scored quanti-
tatively, and by adding the scores the severity of chron-
ic changes are graded into minimal, mild, moderate, and
severe [11]. By applying ISN scoring as the gold stan-
dard, we re-examined and newly scored all available
images that we initially scored as having mild, moder-
ate, or severe CRPC.
Statistical analysis
Dependent on our findings, we categorized outcomes into two
main groups: those with none–mild CRPC versus those with
moderate–severe CRPC. Demographic variables were then
categorized and compared between two outcomes including
country of recruitment, age at diagnosis, body mass index
(BMI) at diagnosis, tobacco smoking status, and alcohol con-
sumption habit. Furthermore, we added variables that could
have a negative impact on our collection protocol such as
tumor size and stage, surgical approach (radical or partial),
and percentage of the medulla (the predominance of medulla
was considered as a possible indicator of full occupation of
cortex by tumor). Kidney-related diseases or medical condi-
tions that could potentially confound the relation between
CRPC and demographic variables were analyzed, including
self-reported history of hypertension, diabetes mellitus,
nephrolithiasis, chronic kidney disease, and ever use of non-
steroidal anti-inflammatory drugs (NSAIDs). Logistic regres-
sion models were used to calculate unadjusted and adjusted
odds ratios (ORs) and 95% confidence intervals (CIs). In all
analyses, unexposed groups were the reference. For numerical
variables, lowest category was considered as a reference. To
study the association between country and CRPC, we used
three models to include co-variables for adjustment: model 1
includes age (5 levels of age groups), sex, and percentage of
the medulla (4 categories); in model 2, we added stage of the
tumor (4 levels) and tumor size ( 4 categories); in model 3, we
added 3 binary variables including history of diabetes
mellitus, hypertension, and NSAID use to model 1.
We evaluated the performance of our scoring by comparing
it with the ISN scoring method. Also, we used multinominal
regression analysis to compare geographical residence (as pre-
dictor) association with the presence of individual compo-
nents of CRPC without applying any score which included:
only GS and at any level, pathologies limited to IFTA with no
GS, presence of both GS and IFTA, and absence of any path-
ological change. Age, gender, and presence of inflammation
were included in the model.
Results
The examined images had the good quality for the purpose of
this evaluation (Supplementary Figures 1 to 7). Of the 1045
initially selected tissues, 33 were excluded due to the exclu-
sive presence of renal medulla in which evaluation of renal
cortical structures was not possible. Table 1 summarizes the
demographic characteristics as well as potential confounders
of the examined patients by grouping them into two categories
of CRPC as the outcome of interest. In 1012 examined ones,
836 (82.6%) did not show significant parenchymal changes
(Supplementary Figure 1), 122 (12.0%) were scored as mild
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CRPC (Supplementary Figure 2), 28 (2.8%) as moderate
(Supplementary Figure 3 and 4), and 26 (2.6%) as severe
CRPC (Supplementary Figures 5 to 7). 958 (94.7%) were
grouped into none–mild CRPC category, and 54 (5.3%) sub-
jects met our criteria for being considered as having
moderate–severe CRPC. Except for age and country of re-
cruitment, no significant difference was observed between
the proportion of moderate–severe CRPC relative to tumor
type, sex, BMI, smoking habit, and alcohol consumption.
The mean age of patients recruited from Russia and the UK
was 57 and 62 years old. Patients from Serbia, Romania, and
the Czech Republic were recruited at the mean age of 60, 63,
and 64 years. In univariate analysis, the odds of having
moderate–severe CRPC showed a significant trend with older
age (P = 0.001). The proportion of both glomerular and tubu-
lar components of CRPC increased by age (Supplementary
Figure 8).
There was a variation in the number of recruited cases in
this study. The Czech Republic with 426 patients provided the
highest number of cases from four different recruiting cities,
followed by Romania (Bucharest), the UK (Leeds), Russia
(Moscow), and Serbia (Belgrade). Clear cell RCC was the
most common histological type of RCC in the entire examined
patients (84.0%), followed by papillary RCC (7.3%). Other
tumor types included chromophobe RCC, collecting duct car-
cinoma, unclassified RCC, and oncocytoma, which altogether
comprised 8.7% of the total examined cases. The proportion
of major RCC histological types did not vary across CRPC
scores (Table 2). The relative probability of detecting GS rath-
er than no changes for patients from the Czech Republic is
more than double the corresponding probability for patients
from Russia or the UK with the same level of inflammation.
Variable degrees of GS were not significantly higher among
Romanians and Serbians compared to Russians. In contrast,
IFTAwas observed four and five times higher in patients from
the Czech Republic and Romania-Serbia, respectively, than
Russians. The relative probability remained unchanged when
those with both GS and IFTA were tested (Table 3).
Table 4 summarizes the result of our analysis to evaluate
whether the observed morphological changes were secondary
to the effect of the tumor on adjacent tissue or self-reported
medical conditions. We used variables such as presence and
percentage of the medulla in non-neoplastic tissues, size of the
tumor, stage at which tumor was operated, and type of surgical
approach to study their impact on the outcome. Radical ne-
phrectomy was the surgical method of choice in 86% of
Russians, 81% of the Czech Republic, and 98% of
Romanian-Serbian cases. The proportion of tumors larger
than 10 cm was similar among Russian and Romanian-
Serbian pat ients (12.5%) and over twice among
Czech Republic cases (25%). Advanced tumor stage (III and
IV) was observed in 27%, 42%, and 38% of patients from
Russia, the Czech Republic, and Romania-Serbia groups.
Our results indicate that apart from surgeon preference, tumor
size was not the major drive for higher proportion of radical
nephrectomies in the group of Romania-Serbia. Furthermore,
we observed a similar proportion of radical nephrectomy be-
tween cases with CRPC (88.9%) and non-CRPC (87.1%).We
compared the method of choice for surgical resection between
GS and IFTA components of CRPC and we observed that
among those with predominant GS, 13% underwent partial
nephrectomy and 17.8% were operated by radical nephrecto-
my approach (P = 0.20). Among cases with predominant
IFTA, surgical approaches were 7.8% and 8.8% for partial
and radical nephrectomy (P = 0.72).
Table 1 Demographic characteristics of patients with moderate–severe
chronic renal parenchymal changes and otherwise in non-neoplastic kid-
ney tissues
Chronic renal parenchymal changes P value
None–mild Moderate–severe
N = 958 N = 54
Recruiting country
Czech Republic 402 (42.0) 24 (44.4) 0.007
Romania 271 (28.3) 9 (16.7)
UK 144 (15.0) 4 (7.4)
Russia 115 (12.0) 13 (24.1)
Serbia 26 (2.7) 4 (7.4)
Sex
Male 601 (62.7) 32 (59.3) 0.6
Female 357 (37.3) 22 (40.7)
Age at diagnosis
< 55 238 (24.8) 6 (11.1) 0.02
55–59 162 (16.9) 5 (9.3)
60–64 190 (19.8) 11 (20.4)
65–69 156 (16.3) 13 (24.1)
> 70 212 (22.1) 19 (35.2)
BMI at diagnosis
< 24.9 221 (23.1) 14 (25.9) 0.9
25.0–29.9 364 (38.0) 19 (35.2)
30.0–34.9 224 (23.4) 14 (25.9)
> 35.0 88 (9.2) 6 (11.1)
Missing 61 (6.4) 1 (1.8)
Tobacco smoking status
Never smoker 484 (50.5) 24 (44.4) 0.4
Ex-smoker 232 (24.2) 18 (33.3)
Current smoker 233 (24.3) 12 (22.2)
Missing 9 (0.9) 0 (0.0)
Alcohol drinking status
Never drinker 481 (50.2) 29 (53.7) 0.8
Ex-drinker 86 (9.0) 7 (13.0)
Current drinker 241 (25.2) 14 (25.9)
Missing 150 (15.6) 4 (7.4)
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Since medical conditions such as hypertension and diabe-
tes mellitus are common in RCC patients and could lead to
morphological changes in renal parenchyma, we evaluated the
association of the observed CRPC with medical conditions
and risk factors for RCC. Almost half of RCC patients report-
ed history of hypertension in this study. In spite of variation in
prevalence of hypertension across countries, hypertensive pa-
tients were equally distributed among CRPC categories (P =
0.4). Self-reporting of diabetes mellitus was recorded in
12.0% of patients. Similar proportion of our two CRPC
groups did not report history of diabetes (73.0% vs. 70.0%).
Although percentage of missing data for diabetes was signif-
icantly higher in none–mild category, there was a trend to-
wards less cases with diabetes among moderate–severe
CRPC (P = 0.03). In our series, 121 patients reported a history
of diabetes (18% of Russians, 10% of Czechs, 11% of
Romanians-Serbians). A total of 511 patients had a history
of hypertension (64% of Russians, 41% of Czechs, and 48%
of Romanians-Serbians). NSAIDs users were defined as those
who take NSAIDs at least once a week for a year. Both groups
of CRPC showed a similar proportion of non-users (68.5% vs.
70.6%) while missing data amongst advanced CRPCs was
less than half of none–mild group (7.0% vs. 17.0%). After
excluding missing data, NSAIDs use was less common
among moderate–severe CRPC group than none–mild one
(P = 0.04).
Table 5 shows ORs for association between country of
recruitment and the CRPCs as outcome. Due to limited num-
ber of events in Serbia (with modest sample size), we pooled
Serbia and Romania to achieve more stable estimate.
Minimally adjusted model (including age, gender, and the
percentage of medulla) showed that those living in Romania
and Serbia experienced more than threefold increased risk of
moderate–severe CRPC comparing to those living in Russia
or the UK. Neighboring geographic sites (Czech Republic)
shows a 1.7-fold increase in risk, although this point estimate
does not remain significant. Adjustment for tumor size, stage,
history of hypertension, history of diabetes, and regular
NSAIDs use did not materially change the estimate.
Comparing our scoring method and the ISN showed that
the two approaches are highly correlated. Estimated diagnos-
tic accuracy of grading used in this study with the gold stan-
dard was calculated based on 82% sensitivity (95% CI:
59.7%–94.8%), 100% specificity (95% CI: 87.2%–100%),
and 0.91 area under ROC (95% CI: 0.83–0.99)
(Supplementary Table 1).
Discussion
Here, we explain the morphological features of renal paren-
chyma in frozen non-neoplastic tissues of patients with RCC
in different geographical sites across central and eastern
Europe, Russia, and the UK, and report a threefold increase
in odds of having CRPC associated with living in Romania
and Serbia. These findings are mainly reported by one pathol-
ogist (BAA) who was also member of the expert
pathology panel of the CAGEKID study. We acknowledge
Table 2 Comparison of severity of chronic renal parenchymal changes in non-neoplastic kidney tissues with tumor type and recruitment country
None–mild Moderate–severe
RCC type Czech Romania Russia Serbia UK Total Czech Romania Russia Serbia UK Total
Clear cell 321 231 93 18 144 807 19 8 10 2 4 43
Papillary 42 16 4 6 0 68 3 1 1 1 0 6
Other 39 24 18 2 0 83 2 0 2 1 0 5
Table 3 Odds ratio of observing four groups of parenchymal changes relevance to geographic residence of cancer patients (adjusted for age, gender,
and presence of inflammation)
Study region None (reference) Only glomerulosclerosis (GS) Interstitial fibrosis or tubular atrophy (IFTA) Both GS and IFTA
N (%) N (%) OR (95%CI) N (%) OR (95%CI) N (%) OR (95%CI)
Russia 255 (31.7) 15 (15.8) Reference 3 (8.6) Reference 6 (7.7) Reference
Czech Republic 303 (37.7) 56 (58.9) 2.41* (1.22–4.74) 22 (62.9) 4.38* (1.20–15.93) 45 (57.7) 4.29** (1.53–12.04)
Romania and Serbia 110 (13.7) 18 (18.9) 2.16 (0.95–4.88) 10 (28.6) 5.22* (1.30–20.98) 21 (26.9) 5.51** (1.77–17.10)




the importance of long-time expertise in uro-nephro pathol-
ogy to examine renal tissues, although our findings
show that the level of expertise might not differentially
affect the classification of tissues into CRPC and other-
wise between countries and it is unlikely that the ob-
served difference is due to this aspect of study design.
Previous reports on the microscopic examination of non-
neoplastic kidney tissue in cancer-related nephrectomies have
shown that the pressure effect from the adjacent tumor causes
pathologic morphological and clinical features while this ef-
fect reduces with distance. Azhar et al. showed that the sever-
ity of pathological findings such as inflammation,
nephrosclerosis, and glomerulosclerosis decreased from se-
vere to mild at 1 to 5 mm distance from tumor [12]. Studies
focused on functionality of adjacent-tumor non-neoplastic re-
nal parenchyma shows glomerular viability reaching to 92%
in 1.0 cm from tumor [13].
To address the possibility of tumor pressure effect being
the origin of our observations, we first relied on our harmo-
nized sample collection procedure in which collection of non-
neoplastic tissues as distant as possible from tumor, and from
renal cortex has been emphasized. Based on these guidelines,
we expect that these tissues were collected distant from tumor,
particularly in more than 5 mm (the distance limit where the
severity of pathological changes caused by tumor decreases
considerably). The observed association between CRPC and
country of origin could not be entirely explained by possibility
of collecting nontumoral tissues closer to tumor in Romania
and Serbia, notably because we observed lower number of
tumors larger than 10 cm in these countries. Also, choice of
surgical method and tumor stage proportion of cases with GS
or IFTA was similar between patients with and without
CRPC. In addition, all of the examined non-neoplastic tissues
were free of tumor in microscopic examination. Adjusted
models for confounders such as tumor size and type of ne-
phrectomy did not change the initial risk estimates. These
findings support the idea that the observed CRPC are not
caused by the pressure effect from tumor and are independent
events.
Hypertension and diabetes mellitus are among the main
causes of chronic and end-stage renal disease and lead to path-
ological parenchymal features mainly in arterioles and glo-
merular capillaries. For precise evaluation of these changes,
special stains such as periodic acid-Schiff and methenamine
silver should complete the H&E staining. Due to the frozen
nature of our samples, we could not perform special stains.
Instead, we applied strict criteria to overcome this limitation.
We categorized all of the mild changes with those with no
significant pathological changes, in the group of none–mild
to avoid overestimation of the observations and to cover any
possibility of missing some diagnostic features due to the use
of frozen tissues. Our qualitative scoring was not only corre-
lated with the quantitative one by ISN but also lower sensitiv-
ity in this method ensures us that our estimated risk might be
even underestimated due to misclassification of true positive
ones among CRPC negative group. In addition, lack of hyper-
tension and diabetes mellitus history was similarly reported in
the both groups of none–mild and moderate–severe CRPC.
When adjusted for these factors, the odds estimate did not
Table 4 Tumor and medical variables among two categories of patients
subdivided by presence/severity of chronic renal parenchymal changes in
non-neoplastic kidney tissues
Chronic renal parenchymal changes P value
None–mild Moderate–severe
N = 958 N = 54
Presence of medulla (%)
0–9 687 (71.7) 41 (71.9) 0.9
10–30 154 (16.1) 8 (14.8)
31–50 51 (5.3) 3 (5.6)
> 50 66 (6.9) 2 (3.7)
Type of nephrectomy
Radical 834 (87.1) 48 (88.9) 0.6
Partial 109 (11.4) 6 (11.1)
Unknown/missing 15 (1.6) 0 (0.0)
Stage at diagnosis
I 430 (44.9) 18 (33.3) 0.6
II 99 (10.3) 7 (13.0)
III 190 (19.8) 12 (22.2)
IV 127 (13.3) 9 (16.7)
Missing 112 (11.7) 8 (14.8)
Tumor size (cm)
T ≤ 4 189 (19.7) 7 (13.0) 0.4
4 < T ≤ 7 373 (38.9) 26 (48.0)
7 < T ≤ 10 221 (23.1) 11 (20.4)
T > 10 164 (17.1) 8(14.8)
Missing 11 (1.0) 2 (3.7)
History of hypertension
No 466 (48.6) 23 (42.6) 0.4
Yes 480 (50.1) 31 (57.4)
Missing 12 (1.2) 0 (0.0)
History of diabetes
No 700 (73.1) 38 (70.4) 0.04
Yes 109 (11.4) 12 (22.2)
Missing 149 (15. 5) 4 (7.4)
History of chronic renal disease
No 728 (76.0) 44 (81.5) 0.2
Yes 26 (2.7) 3 (5.6)
Missing 204 (21.3) 7 (13.0)
Regular NSAID user
No 676 (70.6) 37 (68.5) 0.02
Yes 123 (12.8) 13 (24.1)
Missing 159 (16.6) 4 (7.4)
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change. Self-reported hypertension and diabetes mellitus were
less frequent among Romanians. As a result, these two com-
mon medical conditions are more frequent in our reference
population (Russians) and cannot fully explain the higher
prevalence of CRPC in patients from the Czech Republic or
Romania and Serbia.
The significant presence of CRPC in Romania and Serbia
is of particular interest. Based on the 2019 Global Burden of
Disease (GBD) study database (http://www.healthdata.org/
gbd), and WHO data observatory (https://www.who.int/gho/
en/), the prevalence of chronic kidney disease (CKD) in the
Czech Republic, Romania, and Serbia is 13.5%, 12.3%, and
13.3% respectively. In our study, the report of medical history
of CKD in the Czech Republic and Romania with 426 and 128
recruited cases was 3.5% and 3.9%, respectively. The preva-
lence of CKD in our study group from these two countries is
lower than the reported country prevalence with no statistical
difference between two countries. Among 31 Serbian cases,
only 6 reported a history of CKD. Due to the modest sample
size, we combined patients from Serbia and Romania. CKD
prevalence in the combined group reaches to 6.9%. There is
no statistical difference between CKD prevalence in the
Czech Republic versus combined Romania and Serbia
(Pearson’s chi-squared = 2.99, P = 0.08).
We showed that IFTA is the main driver for the observed
difference between the occurrence and severity of CRPC
across study regions. Interstitial fibrosis and inflammation,
with tubular atrophy, were the predominant features and glo-
merular and vascular changes seem to stem from the intersti-
tial disease. These features are more suggestive for a chronic
interstitial nephritis (CIN) pattern. CIN is a nonspecific diag-
nosis and identification of a specific reason causing it is not
based on light microscopy only and needs accurate clinical
history and imaging studies, the elements that are missing in
our study. Chronic pyelonephritis, analgesic nephropathy, and
Balkan endemic nephropathy (BEN) are among the most im-
portant specific reasons leading to CIN. BEN was first
reported in the 1950s as a progressive renal disease in the form
of chronic interstitial nephritis affecting the people living in
the Balkan Peninsula along the tributaries of the Danube River
in Bosnia and Herzegovina, Bulgaria, Croatia, Romania, and
Serbia. Data support the etiologic role of dietary exposure to
aristolochic acid (AA) in both BEN and Chinese herbs ne-
phropathy. The association of AA nephropathy with urothelial
carcinoma of the upper urinary tract is shown but such a link
with RCC is not reported [14–16]. We have previously pub-
lished the results of whole-genome sequencing of 94 RCC
patients from the CAGEKID that revealed a striking elevation
of A:T.T:A transversions in 12 out of 14 RCC patients from
Romania, a mutational pattern that is consistent with the ex-
posure to AA [17]. Although the microscopic examination of
non-neoplastic tissues of those patients did not show typical
characteristics of BEN, variably high levels of AA DNA ad-
ducts, ranging from 0.7 to 27.0 adducts per 108, were detected
in them [18]. Eight of those 14 patients were included in this
study. Similar to the previous report, we did not find any
characteristic morphological feature indicative of BEN. Only
two patients had focal and mild interstitial fibrosis and inflam-
mation, categorized in none–mild group, but with AA DNA
adduct level reported as 26.84 and 6.08 per 108 DNA bases.
To further investigate the mystery of RCC in these countries, a
large collection of kidney cancer patients from the
Czech Republic, Romania, and Serbia will be soon analyzed
for the discovery of mutational signatures caused by environ-
mental exposures as part of our ongoing collaborative project,
Mutographs of cancers (https://www.mutographs.org) that
might lead to answer some of the questions in this regard.
To our best knowledge, this study is unique and the first
one to report pathological changes in non-neoplastic kidney
tissues regarding both sample size and geographical diversity
of the patients from countries with variable incidence of RCC.
That is also the first report from Serbia where we observed the
highest proportion (13.3%) of moderate–severe changes in
renal parenchyma.
Table 5 Odds ratio and 95%
confidence interval for
association between country and
observing moderate–severe
chronic renal parenchymal
changes in non-neoplastic kidney
tissues of RCC patients
Recruiting country Odds ratio (95% CI)
Unadjusted Model 1* Model 2** Model 3***
Russia Reference Reference Reference Reference
UK 0. 84 (0.25–2.76) 0.64 (0.19–2.16) 0.59 (0.17–2.01) 0.39 (0.10–1.49)
Czech Republic 1.79 (0.82–3.92) 1.34 (0.59–3.00) 1.54 (0.67–3.57) 1.28 (0.56–2.91)
Romania 3.40 (1.41–8.18) 3.12 (1.26–7.74) 3.16 (1.24–8.03) 2.67 (1.07–6.67)
Serbia 4.63 (1.33–16.08) 5.06 (1.39–18.44) 6.27 (1.40–28.02) 4.37 (1.20–15.96)
Romania and Serbia 3.62 (1.57–8.32) 3.42 (1.44–8.12) 3.53 (1.45–8.58) 2.96 (1.24–7.03)
*Adjusted for age, gender, percentage of medulla
**Adjusted for age, gender, percentage of medulla, stage, tumor size
***Adjusted for age, gender, diabetes, hypertension, NSAID use
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Additionally, this is the first report relying on frozen tissues
for detailed microscopic examination. In the current era of a
growing number of molecular studies based on the use of
frozen tissues to optimize the quality of the high throughput
technologies, it is critical to assess the reliability of morpho-
logical examination of frozen tissues. It was worth mentioning
that properly preserved frozen tissues have acceptable quality
for microscopic examination, although one should be aware of
their limitations. At IARC, we are experienced in treating and
evaluating variable kinds of frozen tissues and performing the
routine microscopic evaluation of frozen tissues for the pur-
pose of genomic studies.
Our study has some limitations. Undoubtedly, we could
have better verified our findings on formalin-fixed paraffin-
embedded (FFPE) tissues that are the gold standard in diag-
nostic pathology. However, we did not have access to FFPE
blocks because of the retrospective nature of the study, collec-
tion of samples in more than 10 years ago, and multicentric
nature of the collection that complicates the access to the pa-
thology archives of the hospitals. Themain limitation of use of
frozen tissues in this study is inability to apply special stains,
which are part of routine practice of nephropathology, partic-
ularly to evaluate glomerular and vascular changes. However,
H&E is good enough for the microscopic evaluation of inter-
stitial and tubular changes, the predominant observed
pathological features.
Additionally, our study suffers from missing clinical and
laboratory data of renal function, because it is based on retro-
spective collection that was designed for another aim.
However, our findings bring the first level of information
and urge for properly designed studies to answer the raised
questions.
In conclusion, we report renal parenchymal patholo-
gies in non-neoplastic kidney tissue of RCC patients in
central and southeastern Europe with the predominance
of CIN pattern rather than primary glomerular disease.
We show that these findings are unlikely to be due to
sampling method or pressure effect of the tumor alone.
The observed association between CRPC and living in
certain geographic areas requires larger population-based
studies to confirm this association in large-scale and
designed studies for this aim.
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